| scholarly article | Q13442814 |
| P50 | author | Alberto Pupi | Q43212796 |
| P2093 | author name string | Lisa Mosconi | |
| Valentina Berti | |||
| P2860 | cites work | Evolving knowledge of sex differences in brain structure, function, and chemistry | Q22337351 |
| Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy | Q28266030 | ||
| Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain | Q30445186 | ||
| Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use | Q30472158 | ||
| Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging | Q30749980 | ||
| Energetic basis of brain activity: implications for neuroimaging. | Q30946727 | ||
| Early detection of Alzheimer's disease using neuroimaging | Q31048702 | ||
| Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. | Q31108510 | ||
| Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging | Q33394454 | ||
| Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging | Q34005144 | ||
| Chemobrain: a systematic review of structural and functional neuroimaging studies. | Q34036628 | ||
| The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. | Q34062645 | ||
| Metabolic mapping of the primary visual system of the monkey by means of the autoradiographic [14C]deoxyglucose technique | Q35038413 | ||
| Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging | Q35879805 | ||
| Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study | Q36859823 | ||
| Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias | Q36990181 | ||
| Early changes in fluorine-18-FDG uptake during radiotherapy | Q73689170 | ||
| FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease | Q37415324 | ||
| Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain". | Q39404791 | ||
| Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose | Q40324066 | ||
| Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction | Q40729150 | ||
| The application of positron emission tomography to the study of the normal menstrual cycle | Q40918257 | ||
| The metabolic topography of normal aging | Q42629288 | ||
| Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography | Q43239602 | ||
| Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography | Q43522749 | ||
| Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET. | Q43688018 | ||
| Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome | Q43788870 | ||
| Age, sex and laterality effects on cerebral glucose metabolism in healthy adults | Q43895433 | ||
| Gender differences in cerebral glucose metabolism: a PET study | Q44041646 | ||
| Variation in FDG uptakes in different regions in normal human brain as a function of the time (30 and 60 minutes) after injection of FDG. | Q44069662 | ||
| Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. | Q44249033 | ||
| Striatal size, glucose metabolic rate, and verbal learning in normal aging | Q44451225 | ||
| Relationship between ethanol-induced changes in brain regional metabolism and its motor, behavioural and cognitive effects | Q44703199 | ||
| Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy | Q44886276 | ||
| Acute effects of ethanol on regional brain glucose metabolism and transport | Q45004127 | ||
| Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study | Q45031451 | ||
| Sensitivity of Cerebral Glucose Metabolism to Age, Gender, Brain Volume, Brain Atrophy, and Cerebrovascular Risk Factors | Q45268084 | ||
| Positron emission tomography study of regional cerebral metabolism in humans during isoflurane anesthesia. | Q45968928 | ||
| Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow | Q46209994 | ||
| Changes in glucose metabolism due to aging and gender-related differences in the healthy human brain | Q46356181 | ||
| Brain FDG PET study of normal aging in Japanese: effect of atrophy correction | Q46368741 | ||
| Long-term frontal brain metabolic changes in cocaine abusers | Q46476948 | ||
| Low doses of alcohol substantially decrease glucose metabolism in the human brain | Q46639065 | ||
| Effects of hyperglycemia on FDG uptake in human brain and glioma. | Q48094584 | ||
| Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia | Q48154277 | ||
| Gender-related differences in regional cerebral glucose metabolism in normal volunteers | Q48184813 | ||
| Positron emission tomography study of human brain functional development | Q48199527 | ||
| Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps | Q48216823 | ||
| Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography | Q48250808 | ||
| Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography | Q48316725 | ||
| Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). | Q48331353 | ||
| Gender differences in cerebellar metabolism: test-retest reproducibility | Q48823074 | ||
| Preservation of limbic and paralimbic structures in aging. | Q48913941 | ||
| Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. | Q51029092 | ||
| Regional brain metabolism during alcohol intoxication. | Q51079562 | ||
| Sex- and age-related differences in brain FDG metabolism of healthy adults: an SPM analysis. | Q51502944 | ||
| Energetics of functional activation in neural tissues. | Q51987482 | ||
| The role of hippocampus and frontal cortex in age-related memory changes: a PET study. | Q52048492 | ||
| Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes. | Q52075251 | ||
| Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids | Q57269654 | ||
| Cerebral glucose metabolic rates in normal human females versus normal males | Q68827995 | ||
| Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol | Q70835005 | ||
| Accurate attenuation correction despite movement during PET imaging | Q72116802 | ||
| Sex differences in regional cerebral glucose metabolism during a resting state | Q72417503 | ||
| Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging | Q73251630 | ||
| P433 | issue | 2 | |
| P921 | main subject | computed tomography | Q32566 |
| tomography | Q841267 | ||
| P304 | page(s) | 129-140 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | PET clinics | Q26842869 |
| P1476 | title | Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging | |
| P478 | volume | 9 |
| Q47813203 | 2-18F-fluoro-2-deoxyglucose positron emission tomography in delirium |
| Q47824838 | Alteration of Copper Fluxes in Brain Aging: A Longitudinal Study in Rodent Using 64CuCl2-PET/CT. |
| Q47141424 | Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET. |
| Q92921065 | Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals |
| Q90548352 | Coexistence of cerebral hypometabolism and neuroinflammation in the thalamo-limbic-brainstem region in young women with functional somatic syndrome |
| Q58111005 | Comparison of EEG microstates with resting state fMRI and FDG-PET measures in the default mode network via simultaneously recorded trimodal (PET/MR/EEG) data |
| Q89737567 | Effect of various blood glucose levels on regional FDG uptake in the brain |
| Q38576278 | FDG-PET Contributions to the Pathophysiology of Memory Impairment. |
| Q90723352 | Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients |
| Q60368756 | Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment |
| Q64266624 | Links Between Metabolic and Structural Changes in the Brain of Cognitively Normal Older Adults: A 4-Year Longitudinal Follow-Up |
| Q48066114 | Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency? |
| Q96680508 | Metabolic activity in subcallosal cingulate predicts response to deep brain stimulation for depression |
| Q59809739 | Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation Therapy |
| Q42690171 | Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. |
| Q64096467 | Quantifying normal human brain metabolism using hyperpolarized [1-C]pyruvate and magnetic resonance imaging |
| Q64104581 | Region-specific association between basal blood insulin and cerebral glucose metabolism in older adults |
| Q47646742 | Targeting Metabolism for Cancer Therapy. |
| Q47111896 | The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain |
| Q89425444 | The Role of Nutrition in Cognitive Function and Brain Ageing in the Elderly |
| Q58760103 | Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1 |
| Q41495713 | Validation of true low-dose 18F-FDG PET of the brain |
| Q38741225 | Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline |
Search more.